Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3230
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05089617 | To Evaluate the Safety, Tolerability, and Pharmacokinetics of YG1699（Antidiabetic） in Healthy Chinese Sbjects | ||
| NCT00554190 | Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel | ||
| NCT04266197 | Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study | ||
| NCT06789913 | A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation | ||
| NCT06729723 | Exploratory Study on the Effect of SAT-001 on Choroidal Thickness in Pediatric Myopia Patients | ||
| NCT01263379 | Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa | ||
| NCT03627403 | Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors | ||
| NCT06812325 | A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) | ||
| NCT00080418 | Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer | ||
| NCT05540860 | A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX) | ||
| NCT04607668 | Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): | ||
| NCT06205290 | A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies | ||
| NCT05256290 | Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations | ||
| NCT05011162 | "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia | ||
| NCT05902988 | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | ||
| NCT00620503 | Proellex® Pharmacokinetic Bridging Study II | ||
| NCT02301156 | Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL) | ||
| NCT03591926 | A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF) | ||
| NCT03633591 | A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone | ||
| NCT02384460 | ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa | ||
| NCT05368038 | ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program | ||
| NCT06281158 | A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-DNL343 Following a Single Oral Dose in Healthy Male Participants | ||
| NCT03507543 | The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors | ||
| NCT02166476 | Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP | ||
| NCT06537817 | Study to Evaluate HT-4253 in Healthy Subjects | ||
| NCT06533059 | A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors | ||
| NCT02323646 | Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids | ||
| NCT05448391 | A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF) | ||
| NCT05039359 | Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation | ||
| NCT02724527 | Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor | ||
| NCT06874010 | A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia | ||
| NCT06603623 | Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine | ||
| NCT02293980 | A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) | ||
| NCT05113745 | A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) | ||
| NCT03710707 | Study to Evaluate DNL201 in Subjects With Parkinson's Disease | ||
| NCT00290563 | Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003) | ||
| NCT04520321 | A Phase 1/ Phase 2 Study of TTHX1114(NM141) | ||
| NCT06439563 | Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers | ||
| NCT01746784 | Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation | ||
| NCT05947955 | Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) | ||
| NCT03631472 | Gala Early Feasibility Study of RheOx | ||
| NCT01711671 | A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT06214793 | Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) | ||
| NCT00292084 | An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection | ||
| NCT07007052 | Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients | ||
| NCT00534352 | A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment). | ||
| NCT01898715 | Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma | ||
| NCT04522817 | CLBS119 for Repair of COVID-19 Induced Pulmonary Damage | ||
| NCT02643082 | A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD | ||
| NCT01287338 | A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model. |
